SEC FORM 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:		3235-0287
Expires:	December 31, 2014
Estimated average burden
hours per response:		0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person ^*

Curnes Nelson Bunker

(Last)

(First)

(Middle)

2802 FLINTROCK TRACE, SUITE 226

(Street)

AUSTIN

78738

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Mobia Medical, Inc. [ MOBI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/11/2026		C		283,895	A	⁽¹⁾	303,322	D
Common Stock	05/11/2026		X		13,684	A	$ 14.653	317,006	D
Common Stock	05/11/2026		F		13,368	D	$ 15	303,638	D
Common Stock	05/11/2026		C		5,742	A	⁽¹⁾	5,742	I	By Family Trusts
Common Stock	05/11/2026		C		476,485	A	⁽¹⁾	476,485	I	By Exceller Hunt Microtransponder 2017, LP
Common Stock	05/11/2026		C		333,333	A	⁽²⁾	809,818	I	By Exceller Hunt Microtransponder 2017, LP
Common Stock	05/11/2026		C		175,077	A	⁽²⁾	175,077	I	By Curnes Fund 2001

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Convertible Notes	⁽²⁾	01/30/2026⁽³⁾		A		2,000,000		⁽²⁾	⁽²⁾	Common Stock	166,666	$ 2,000,000	2,000,000	I	By Curnes Fund 2001
Convertible Notes	⁽²⁾	01/30/2026⁽³⁾		A		4,000,000		⁽²⁾	⁽²⁾	Common Stock	333,333	$ 4,000,000	4,000,000	I	By Exceller Hunt Microtransponder 2017, LP
Convertible Notes	⁽²⁾	02/05/2026⁽³⁾		A		100,937.62		⁽²⁾	⁽²⁾	Common Stock	8,411	$ 100,937.62	2,100,937.62	I	By Curnes Fund 2001
Stock Option	$ 15	05/07/2026		A		206,070		⁽⁴⁾	05/07/2036	Common Stock	206,070	$ 0	206,070	D
Series A Preferred Stock	⁽¹⁾	05/11/2026		C			191,330	⁽¹⁾	⁽¹⁾	Common Stock	54,932	⁽¹⁾	0	D
Series C Preferred Stock	⁽¹⁾	05/11/2026		C			100,000	⁽¹⁾	⁽¹⁾	Common Stock	28,710	⁽¹⁾	0	D
Series D Preferred Stock	⁽¹⁾	05/11/2026		C			383,333	⁽¹⁾	⁽¹⁾	Common Stock	110,058	⁽¹⁾	0	D
Series E-1 Preferred Stock	⁽¹⁾	05/11/2026		C			29,168	⁽¹⁾	⁽¹⁾	Common Stock	8,374	⁽¹⁾	0	D
Series F Preferred Stock	⁽¹⁾	05/11/2026		C			284,986	⁽¹⁾	⁽¹⁾	Common Stock	81,821	⁽¹⁾	0	D
Series C Preferred Stock	⁽¹⁾	05/11/2026		C			20,000	⁽¹⁾	⁽¹⁾	Common Stock	5,742	⁽¹⁾	0	I	By Family Trusts
Series D Preferred Stock	⁽¹⁾	05/11/2026		C			505,269	⁽¹⁾	⁽¹⁾	Common Stock	145,067	⁽¹⁾	0	I	By Exceller Hunt Microtransponder 2017, LP
Series E-1 Preferred Stock	⁽¹⁾	05/11/2026		C			272,271	⁽¹⁾	⁽¹⁾	Common Stock	78,171	⁽¹⁾	0	I	By Exceller Hunt Microtransponder 2017, LP
Series E-2 Preferred Stock	⁽¹⁾	05/11/2026		C			596,219	⁽¹⁾	⁽¹⁾	Common Stock	171,179	⁽¹⁾	0	I	By Exceller Hunt Microtransponder 2017, LP
Series F Preferred Stock	⁽¹⁾	05/11/2026		C			285,846	⁽¹⁾	⁽¹⁾	Common Stock	82,068	⁽¹⁾	0	I	By Exceller Hunt Microtransponder 2017, LP
Warrants	$ 14.653	05/11/2026		X			23,666	⁽⁵⁾	06/13/2033	Common Stock	6,890	⁽⁵⁾	0	D
Warrants	$ 14.653	05/11/2026		X			24,000	⁽⁵⁾	05/24/2033	Common Stock	6,794	⁽⁵⁾	0	D
Convertible Notes	⁽²⁾	05/11/2026		C			2,100,937.62	⁽²⁾	⁽²⁾	Common Stock	175,077	⁽²⁾	0	I	By Curnes Fund 2001
Convertible Notes	⁽²⁾	05/11/2026		C			4,000,000	⁽²⁾	⁽²⁾	Common Stock	333,333	⁽²⁾	0	I	By Exceller Hunt Microtransponder 2017, LP

Explanation of Responses:

1. Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

2. The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

3. This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a).

4. The stock option will vest as to 25% of the underlying shares on May 7, 2027, and will vest thereafter in 36 substantially equal monthly installments.

5. The warrants are currently exercisable. In connection with the Offering, the warrants were exercised according to the terms of the applicable warrant agreement. The warrants have a net exercise provision under which the Reporting Person may, in lieu of payment of the exercise price in cash, surrender the warrants and receive a net amount of shares based on the fair market value of the shares at the time of exercise of the warrants after deduction of the aggregate exercise price.

	/s/ Chase Leavitt, Attorney-in-Fact	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.